David E. Anderson
2017
In 2017, David E. Anderson earned a total compensation of $520.9K as Chief Scientific Officer at VBI Vaccines.
Compensation breakdown
| Bonus | $120,560 |
|---|---|
| Option Awards | $75,800 |
| Salary | $320,000 |
| Other | $4,500 |
| Total | $520,860 |
Anderson received $320K in salary, accounting for 61% of the total pay in 2017.
Anderson also received $120.6K in bonus, $75.8K in option awards and $4.5K in other compensation.
Rankings
In 2017, David E. Anderson's compensation ranked 11,697th out of 14,666 executives tracked by ExecPay. In other words, Anderson earned more than 20.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,697 out of 14,666 | 20th |
Division Manufacturing | 4,594 out of 5,768 | 20th |
Major group Chemicals And Allied Products | 1,678 out of 2,074 | 19th |
Industry group Drugs | 1,388 out of 1,730 | 20th |
Industry Pharmaceutical Preparations | 1,083 out of 1,329 | 19th |
Source: SEC filing on April 29, 2019.
Anderson's colleagues
We found two more compensation records of executives who worked with David E. Anderson at VBI Vaccines in 2017.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019